Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 1

1(16.7%)

Phase 2

1(16.7%)

Phase 3

1(16.7%)

6Total

N/A(3)

Phase 1(1)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06741839Not ApplicableRecruiting

Confocal Laser Endomicroscopy Guided Medical Thoracoscopy for the Diagnosis of Pleural Disease

Role: collaborator

NCT07198685Not ApplicableNot Yet Recruiting

6 Months of Bedaquiline(BDQ), Delamanid(DLM), Linezolid(LZD) and Levofloxacin(LFX) in RR-TB Patients in Hubei Province

Role: lead

NCT07191834Not Yet Recruiting

A Study on the Short - Course Treatment Regimen Containing Pretomanid for Diabetes Mellitus Complicated With Rifampicin - Resistant/Multidrug - Resistant Pulmonary Tuberculosis

Role: lead

NCT07152639Phase 3Recruiting

Clinical Trial to Evaluate the Efficacy and Safety of EEC for the Diagnosis of Mycobacterium Tuberculosis Infection in People Aged 3 Years and Above

Role: collaborator

NCT07126639Not ApplicableNot Yet Recruiting

A Study on the Short-course Treatment Regimen Containing Pretomanid for Drug-resistant Tuberculosis

Role: lead

NCT04538911Phase 1Active Not Recruiting

Phase I Clinical Protocol for Pre-evaluation of the Safety of BCG-PPD in Tuberculosis Patients

Role: collaborator

NCT06224036Phase 2Unknown

Clinical Study of JDB0131 Benzenesulfonate Tablets in Patients With Drug-sensitive Pulmonary Tuberculosis

Role: collaborator

All 7 trials loaded